<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000726.v1.p1" parentStudy="phs000726.v1.p1" createDate="2014-03-12" modDate="2014-05-02">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>Bryan J. Traynor, PhD, M.D</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Daniel B. Drachman, M.D</td><td>Johns Hopkins University, Baltimore, MD, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Alan E. Renton</td><td>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Hannah A. Pliner</td><td>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Co-Investigators</td><td>Carlo Provenzano</td><td>Institute of General Pathology, Catholic University, Rome, Italy</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genome-wide Association Study of Myasthenia Gravis</StudyNameEntrez>
	<StudyNameReportPage>Genome-wide Association Study of Myasthenia Gravis</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The purpose of this project was to conduct a genome-wide associate study to search for the genetic factors that predispose to myasthenia gravis. The rationale for this study lies in the fact that, although the immunological and physiological processes affecting the neuromuscular junctions of myasthenia gravis patients are well understood, the spectrum of genetic factors that predispose to myasthenia gravis and influence its disease manifestations are not well known. Identification of the myasthenia gravis-related genes will shed light on the fundamental cellular events underlying myasthenia gravis, and will provide focus for research aimed at developing therapies that alter the natural course of the disease.</p> <p>A consortium of fourteen institutions in North America collected DNA samples from 1028 people diagnosed with autoimmune myasthenia gravis. Relevant clinical data have been collected for each patient, including age of onset, severity of disease, response to drug therapy, personal and family history of other autoimmune diseases. Genotyping of the case cohort was performed in the Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD. Genotyping of the case cohort was performed using the HumanOmniExpress-12v1_C SNP array manufactured by Illumina Inc. For the control cohort, we downloaded genotype data from dbGAP (accession <a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000196.v2.p1">phs000196.v2.p1</a>) for 1,998 US neurologically normal individuals. The control cohort had been previously genotyped at the Center for Inherited Disease Research at Johns Hopkins University on HumanOmni1-Quad version 1.0B beadchips (Illumina) as part of the NeuroGenetics Research Consortium GWAS of Parkinson&#39;s disease. Analyses were confined to the 677,673 autosomal SNPs that were common to both chips.</p> <p>Of the 1028 samples which were genotyped, 21 samples were excluded due to mismatched genders, 9 were excluded due to low genotype call rate, 5 samples were excluded as duplicates, and 25 samples were excluded as ethnic outliers. The remaining 972 samples were used in analysis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<b>Inclusion</b>: <ul><li>Diagnosed as having myasthenia gravis by a neurologist specializing in myasthenia gravis.</li></ul> <ul><li>Positive AChR antibody titer.</li></ul> <ul><li>Onset of symptoms after 18 years of age.</li></ul> <ul><li>Non-Hispanic Caucasian ethnicity.</li></ul> <br/> <b>Exclusion</b>: <ul><li>Positive test results for antibody to anti-muscle-specific kinase (anti-MuSK).</li></ul>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Myasthenia gravis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>Bryan J. Traynor, PhD, M.D</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Daniel B. Drachman, M.D</AttName>
			<Institution>Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Alan E. Renton</AttName>
			<Institution>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Hannah A. Pliner</AttName>
			<Institution>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Carlo Provenzano</AttName>
			<Institution>Institute of General Pathology, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Amelia Evoli</AttName>
			<Institution>Institute of Neurology, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michael A. Nalls</AttName>
			<Institution>Molecular Genetics Section, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Giuseppe Marangi</AttName>
			<Institution>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA;  Institute of Medical Genetics, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Yevgeniya Abramzon</AttName>
			<Institution>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Sampath Arepalli</AttName>
			<Institution>Genomics Technology Group, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Sean Chong</AttName>
			<Institution>Genomics Technology Group, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Dena G. Hernandez</AttName>
			<Institution>Genomics Technology Group, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Emanuela Bartoccioni</AttName>
			<Institution>Institute of General Pathology, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Flavia Scuderi</AttName>
			<Institution>Institute of General Pathology, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Roberta Ricciardi</AttName>
			<Institution>Department of Neuroscience, Cisanello Hospital, University of Pisa, Pisa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michelangelo Maestri</AttName>
			<Institution>Department of Neuroscience, Cisanello Hospital, University of Pisa, Pisa, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>J. Raphael Gibbs</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Edoardo Errichiello</AttName>
			<Institution>Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA; &#39;Rita Levi Montalcini&#39; Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Adriano Chi&#242;</AttName>
			<Institution>&#39;Rita Levi Montalcini&#39; Department of Neuroscience, University of Turin, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Gabriella Restagno</AttName>
			<Institution>Molecular Genetics Unit, Department of Clinical Pathology, A.S.O. O.I.R.M.-S. Anna, Turin, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Mario Sabatelli</AttName>
			<Institution>Mario Sabatelli	Institute of Neurology, Catholic University, Rome, Italy</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michael Benatar</AttName>
			<Institution>Department of Neurology, University of Miami Health System, Miami, FL, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Richard Barohn</AttName>
			<Institution>Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Mazen Demachkie</AttName>
			<Institution>Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Julie Rowin</AttName>
			<Institution>Department of Neurology, University of Illinois College of Medicine, Chicago, IL, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>John Kissel</AttName>
			<Institution>Department of Neurology, Ohio State University Medical Center, Columbus, OH, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Miriam Freimer</AttName>
			<Institution>Department of Neurology, Ohio State University Medical Center, Columbus, OH, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Henry J. Kaminski</AttName>
			<Institution>Department of Neurology, George Washington University, Washington, DC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Don B. Sanders</AttName>
			<Institution>Department of Neurology, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Janice M. Massey</AttName>
			<Institution>Department of Neurology, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>James F. Howard Jr</AttName>
			<Institution>Department of Neurology, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michael W. Nicolle</AttName>
			<Institution>Department of Neurology, London Health Sciences Centre, London, ON, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Robert M. Pascuzzi</AttName>
			<Institution>Department of Neurology, Indiana University-Purdue University, Indianapolis, IN, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Alan Pestronk</AttName>
			<Institution>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Julaine Florence</AttName>
			<Institution>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Zaeem Siddiqi</AttName>
			<Institution>Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Gil Wolfe</AttName>
			<Institution>Department of Neurology, University at Buffalo SMBS, State University of New York, Buffalo, NY, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>David Richman</AttName>
			<Institution>Department of Neurology, UC Davis Medical Center, Davis, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Joel Oger</AttName>
			<Institution>Department of Neurology, Vancouver Coastal Health, Vancouver, BC, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Janel Johnson</AttName>
			<Institution>Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institutes on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Bernadette Lipscomb</AttName>
			<Institution>Department of Neurology, Duke University Medical Center, Durham, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Manisha Chopra</AttName>
			<Institution>Department of Neurology, UNC Chapel Hill, Chapel Hill, NC, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Wilma J. Koopman</AttName>
			<Institution>Department of Neurology, London Health Sciences Centre, London, ON, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Charlie Wulf</AttName>
			<Institution>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Derrick Blackmore</AttName>
			<Institution>Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Aimee Soloway</AttName>
			<Institution>Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Srikanth Muppidi</AttName>
			<Institution>Department of Neurology, University at Buffalo SMBS, State University of New York, Buffalo, NY, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michele Mezei</AttName>
			<Institution>Department of Neurology, Vancouver Coastal Health, Vancouver, BC, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Theresa Jiwa</AttName>
			<Institution>Department of Neurology, Vancouver Coastal Health, Vancouver, BC, Canada</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Mark Macek</AttName>
			<Institution>Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Sonja W. Scholz</AttName>
			<Institution>Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Andrea Corse</AttName>
			<Institution>Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Vinay Chaudhry</AttName>
			<Institution>Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>Case cohort genotype data submitted to dbGaP in March 2014.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU-IRB" longName="General Research Use (IRB)"/>
	</ConsentGroups>
</Configuration>



</Study>

</Studies>

</GaPExchange>
